Sculpher MJ - Search Results

1

Economic issues in the prevention of vertical transmission of HIV.

Ades AE, Ratcliffe J, Gibb DM, Sculpher MJ. Ades AE, et al. Among authors: sculpher mj. Pharmacoeconomics. 2000 Jul;18(1):9-22. doi: 10.2165/00019053-200018010-00002. Pharmacoeconomics. 2000. PMID: 11010608 Review.

2

Modelling the costs of paediatric HIV infection and AIDS: comparison of infected children born to screened and unscreened mothers.

Sculpher MJ, Gibb D, Ades AE, Ratcliffe J, Duong T. Sculpher MJ, et al. AIDS. 1998 Jul 30;12(11):1371-80. doi: 10.1097/00002030-199811000-00020. AIDS. 1998. PMID: 9708418

3

Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness.

Ratcliffe J, Ades AE, Gibb D, Sculpher MJ, Briggs AH. Ratcliffe J, et al. Among authors: sculpher mj. AIDS. 1998 Jul 30;12(11):1381-8. doi: 10.1097/00002030-199811000-00021. AIDS. 1998. PMID: 9708419

4

The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

Sculpher MJ, Buxton MJ. Sculpher MJ, et al. Pharmacoeconomics. 1993 Nov;4(5):345-52. doi: 10.2165/00019053-199304050-00005. Pharmacoeconomics. 1993. PMID: 10146873 Clinical Trial.

5

An introduction to Markov modelling for economic evaluation.

Briggs A, Sculpher M. Briggs A, et al. Pharmacoeconomics. 1998 Apr;13(4):397-409. doi: 10.2165/00019053-199813040-00003. Pharmacoeconomics. 1998. PMID: 10178664 Review.

6

Costs and benefits to the mother of antenatal HIV testing: estimates from simulation modelling.

Gibb DM, Ades AE, Gupta R, Sculpher MJ. Gibb DM, et al. Among authors: sculpher mj. AIDS. 1999 Aug 20;13(12):1569-76. doi: 10.1097/00002030-199908200-00018. AIDS. 1999. PMID: 10465082

7

Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Brown J, Sculpher M. Brown J, et al. Pharmacoeconomics. 1999 Jul;16(1):17-31. doi: 10.2165/00019053-199916010-00003. Pharmacoeconomics. 1999. PMID: 10539119 Review.

8

Cost effectiveness analysis of antenatal HIV screening in United Kingdom.

Ades AE, Sculpher MJ, Gibb DM, Gupta R, Ratcliffe J. Ades AE, et al. Among authors: sculpher mj. BMJ. 1999 Nov 6;319(7219):1230-4. doi: 10.1136/bmj.319.7219.1230. BMJ. 1999. PMID: 10550083 Free PMC article.

9

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.

Sculpher M, Fenwick E, Claxton K. Sculpher M, et al. Pharmacoeconomics. 2000 May;17(5):461-77. doi: 10.2165/00019053-200017050-00005. Pharmacoeconomics. 2000. PMID: 10977388 Review.

10

Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.

Gilbert RE, Augood C, Gupta R, Ades AE, Logan S, Sculpher M, van Der Meulen JH. Gilbert RE, et al. BMJ. 2001 Aug 25;323(7310):423-5. doi: 10.1136/bmj.323.7310.423. BMJ. 2001. PMID: 11520837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters